Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
3.520
-0.100 (-2.76%)
Nov 12, 2024, 4:00 PM EST - Market closed
Mural Oncology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 45.53 | 40.91 | 27.63 | 25.25 |
| Research & Development | 126.01 | 153.73 | 157.29 | 150.12 |
| Operating Expenses | 171.54 | 194.64 | 184.92 | 175.37 |
| Operating Income | -171.54 | -194.64 | -184.92 | -175.37 |
| Other Non Operating Income (Expenses) | 0.95 | 0.95 | - | - |
| EBT Excluding Unusual Items | -164.76 | -193.69 | -184.92 | -175.37 |
| Merger & Restructuring Charges | -1.6 | -1.6 | - | - |
| Pretax Income | -166.36 | -195.29 | -184.92 | -175.37 |
| Income Tax Expense | 6.94 | 12.16 | 4.88 | 0.07 |
| Net Income | -173.3 | -207.45 | -189.81 | -175.43 |
| Net Income to Common | -173.3 | -207.45 | -189.81 | -175.43 |
| Shares Outstanding (Basic) | 17 | 17 | 17 | - |
| Shares Outstanding (Diluted) | 17 | 17 | 17 | - |
| Shares Change (YoY) | 0.51% | - | - | - |
| EPS (Basic) | -10.33 | -12.43 | -11.37 | - |
| EPS (Diluted) | -10.33 | -12.43 | -11.37 | - |
| Free Cash Flow | -162.29 | -197.7 | -174.1 | -161.05 |
| Free Cash Flow Per Share | -9.67 | -11.85 | -10.43 | - |
| EBITDA | -168.4 | -192.07 | -183.38 | -173.89 |
| D&A For EBITDA | 3.14 | 2.57 | 1.54 | 1.47 |
| EBIT | -171.54 | -194.64 | -184.92 | -175.37 |
Source: S&P Capital IQ. Standard template.
Financial Sources.